APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antacids

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antacids Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchAntacids Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antacids Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Antacids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antacids Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antacids Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Antacids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antacids market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antacids market include Xiuzheng Pharma, Takeda Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Reckitt Benckiser, CONBA, Pfizer and CR SANJIU, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antacids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antacids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antacids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antacids market size, projected growth trends, production technologies, key applications, and end-use industries.

Antacids Segment by Company

Xiuzheng Pharma

Takeda Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Reckitt Benckiser

CONBA

Pfizer

CR SANJIU

GlaxoSmithKline

Bausch Health

Procter & Gamble

Bayer

AstraZeneca

Antacids Segment by Type

Non-Systemic Antacids

Systemic Antacids

Antacids Segment by Application

Rx Drug

OTC Drug

Antacids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antacids status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antacids market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antacids significant trends, drivers, influence factors in global and regions.

6. To analyze Antacids competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antacids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antacids market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antacids industry.

Chapter 3: Detailed analysis of Antacids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antacids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antacids in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antacids Industry Trends Table 2. Antacids Industry Drivers Table 3. Antacids Industry Opportunities and Challenges Table 4. Antacids Industry Restraints Table 5. Global Antacids Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antacids Revenue Share by Company (2021-2026) Table 7. Global Antacids Sales Volume by Company (k units) & (2021-2026) Table 8. Global Antacids Sales Volume Share by Company (2021-2026) Table 9. Global Antacids Average Price (US$/unit) of Company (2021-2026) Table 10. Global Antacids Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antacids Key Company Manufacturing Base & Headquarters Table 12. Global Antacids Company, Product Type & Application Table 13. Global Antacids Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antacids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Non-Systemic Antacids Table 18. Significant Companies of Systemic Antacids Table 19. Global Antacids Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Antacids Sales Volume by Type (2021-2026) & (k units) Table 21. Global Antacids Sales Volume by Type (2027-2032) & (k units) Table 22. Global Antacids Sales Volume Share by Type (2021-2026) Table 23. Global Antacids Sales Volume Share by Type (2027-2032) Table 24. Global Antacids Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Antacids Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Antacids Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Antacids Sales Value Share by Type (2021-2026) Table 28. Global Antacids Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Rx Drug Table 30. Significant Companies of OTC Drug Table 31. Global Antacids Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Antacids Sales Volume by Application (2021-2026) & (k units) Table 33. Global Antacids Sales Volume by Application (2027-2032) & (k units) Table 34. Global Antacids Sales Volume Share by Application (2021-2026) Table 35. Global Antacids Sales Volume Share by Application (2027-2032) Table 36. Global Antacids Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Antacids Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Antacids Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Antacids Sales Value Share by Application (2021-2026) Table 40. Global Antacids Sales Value Share by Application (2027-2032) Table 41. Global Antacids Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Antacids Sales by Region (2021-2026) & (k units) Table 43. Global Antacids Sales Market Share by Region (2021-2026) Table 44. Global Antacids Sales by Region (2027-2032) & (k units) Table 45. Global Antacids Sales Market Share by Region (2027-2032) Table 46. Global Antacids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Antacids Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Antacids Sales Value Share by Region (2021-2026) Table 49. Global Antacids Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Antacids Sales Value Share by Region (2027-2032) Table 51. Global Antacids Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Antacids Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Antacids Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Antacids Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Antacids Sales by Country (2021-2026) & (k units) Table 56. Global Antacids Sales Market Share by Country (2021-2026) Table 57. Global Antacids Sales by Country (2027-2032) & (k units) Table 58. Global Antacids Sales Market Share by Country (2027-2032) Table 59. Global Antacids Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Antacids Sales Value Market Share by Country (2021-2026) Table 61. Global Antacids Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Antacids Sales Value Market Share by Country (2027-2032) Table 63. Xiuzheng Pharma Company Information Table 64. Xiuzheng Pharma Business Overview Table 65. Xiuzheng Pharma Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Xiuzheng Pharma Antacids Product Portfolio Table 67. Xiuzheng Pharma Recent Development Table 68. Takeda Pharmaceutical Company Information Table 69. Takeda Pharmaceutical Business Overview Table 70. Takeda Pharmaceutical Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Takeda Pharmaceutical Antacids Product Portfolio Table 72. Takeda Pharmaceutical Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Antacids Product Portfolio Table 77. Sanofi Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Antacids Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Novartis Antacids Product Portfolio Table 87. Novartis Recent Development Table 88. Reckitt Benckiser Company Information Table 89. Reckitt Benckiser Business Overview Table 90. Reckitt Benckiser Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Reckitt Benckiser Antacids Product Portfolio Table 92. Reckitt Benckiser Recent Development Table 93. CONBA Company Information Table 94. CONBA Business Overview Table 95. CONBA Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. CONBA Antacids Product Portfolio Table 97. CONBA Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Pfizer Antacids Product Portfolio Table 102. Pfizer Recent Development Table 103. CR SANJIU Company Information Table 104. CR SANJIU Business Overview Table 105. CR SANJIU Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. CR SANJIU Antacids Product Portfolio Table 107. CR SANJIU Recent Development Table 108. GlaxoSmithKline Company Information Table 109. GlaxoSmithKline Business Overview Table 110. GlaxoSmithKline Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. GlaxoSmithKline Antacids Product Portfolio Table 112. GlaxoSmithKline Recent Development Table 113. Bausch Health Company Information Table 114. Bausch Health Business Overview Table 115. Bausch Health Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Bausch Health Antacids Product Portfolio Table 117. Bausch Health Recent Development Table 118. Procter & Gamble Company Information Table 119. Procter & Gamble Business Overview Table 120. Procter & Gamble Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Procter & Gamble Antacids Product Portfolio Table 122. Procter & Gamble Recent Development Table 123. Bayer Company Information Table 124. Bayer Business Overview Table 125. Bayer Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Bayer Antacids Product Portfolio Table 127. Bayer Recent Development Table 128. AstraZeneca Company Information Table 129. AstraZeneca Business Overview Table 130. AstraZeneca Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. AstraZeneca Antacids Product Portfolio Table 132. AstraZeneca Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Antacids Distributors List Table 136. Antacids Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Antacids Product Image Figure 2. Global Antacids Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antacids Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antacids Sales (2021-2032) & (k units) Figure 5. Global Antacids Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Antacids Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Non-Systemic Antacids Image Figure 10. Systemic Antacids Image Figure 11. Global Antacids Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Antacids Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Antacids Sales Volume Share by Type (2021-2032) Figure 14. Global Antacids Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Antacids Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Antacids Sales Value Share by Type (2021-2032) Figure 17. Rx Drug Image Figure 18. OTC Drug Image Figure 19. Global Antacids Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Antacids Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Antacids Sales Volume Share by Application (2021-2032) Figure 22. Global Antacids Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Antacids Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Antacids Sales Value Share by Application (2021-2032) Figure 25. Global Antacids Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Antacids Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Antacids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Antacids Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Antacids Sales Value (2021-2032) & (US$ Million) Figure 30. North America Antacids Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Antacids Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Antacids Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Antacids Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Antacids Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Antacids Sales Value (2021-2032) & (US$ Million) Figure 36. South America Antacids Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Antacids Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Antacids Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Antacids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Antacids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Antacids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Antacids Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Antacids Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Non-Systemic Antacids
  • Systemic Antacids
Applications
  • Rx Drug
  • OTC Drug
Companies covered
  • Xiuzheng Pharma
  • Takeda Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Reckitt Benckiser
  • CONBA
  • Pfizer
  • CR SANJIU
  • GlaxoSmithKline
  • Bausch Health
  • Procter & Gamble
  • Bayer
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antacids Sales Value (2021-2032)
  4. 1.2.2 Global Antacids Sales Volume (2021-2032)
  5. 1.2.3 Global Antacids Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antacids Market Dynamics
  1. 2.1 Antacids Industry Trends
  2. 2.2 Antacids Industry Drivers
  3. 2.3 Antacids Industry Opportunities and Challenges
  4. 2.4 Antacids Industry Restraints
3 Antacids Market by Company
  1. 3.1 Global Antacids Company Revenue Ranking in 2025
  2. 3.2 Global Antacids Revenue by Company (2021-2026)
  3. 3.3 Global Antacids Sales Volume by Company (2021-2026)
  4. 3.4 Global Antacids Average Price by Company (2021-2026)
  5. 3.5 Global Antacids Company Ranking (2024-2026)
  6. 3.6 Global Antacids Company Manufacturing Base and Headquarters
  7. 3.7 Global Antacids Company Product Type and Application
  8. 3.8 Global Antacids Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antacids Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antacids Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antacids Market by Type
  1. 4.1 Antacids Type Introduction
  2. 4.1.1 Non-Systemic Antacids
  3. 4.1.2 Systemic Antacids
  4. 4.2 Global Antacids Sales Volume by Type
  5. 4.2.1 Global Antacids Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antacids Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Antacids Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Antacids Sales Value by Type
  9. 4.3.1 Global Antacids Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Antacids Sales Value by Type (2021-2032)
  11. 4.3.3 Global Antacids Sales Value Share by Type (2021-2032)
5 Antacids Market by Application
  1. 5.1 Antacids Application Introduction
  2. 5.1.1 Rx Drug
  3. 5.1.2 OTC Drug
  4. 5.2 Global Antacids Sales Volume by Application
  5. 5.2.1 Global Antacids Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antacids Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Antacids Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Antacids Sales Value by Application
  9. 5.3.1 Global Antacids Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antacids Sales Value by Application (2021-2032)
  11. 5.3.3 Global Antacids Sales Value Share by Application (2021-2032)
6 Antacids Regional Sales and Value Analysis
  1. 6.1 Global Antacids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antacids Sales by Region (2021-2032)
  3. 6.2.1 Global Antacids Sales by Region: 2021-2026
  4. 6.2.2 Global Antacids Sales by Region (2027-2032)
  5. 6.3 Global Antacids Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antacids Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antacids Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antacids Sales Value by Region (2027-2032)
  9. 6.5 Global Antacids Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antacids Sales Value (2021-2032)
  12. 6.6.2 North America Antacids Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antacids Sales Value (2021-2032)
  15. 6.7.2 Europe Antacids Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antacids Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antacids Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antacids Sales Value (2021-2032)
  21. 6.9.2 South America Antacids Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antacids Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antacids Sales Value Share by Country, 2025 VS 2032
7 Antacids Country-level Sales and Value Analysis
  1. 7.1 Global Antacids Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antacids Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antacids Sales by Country (2021-2032)
  4. 7.3.1 Global Antacids Sales by Country (2021-2026)
  5. 7.3.2 Global Antacids Sales by Country (2027-2032)
  6. 7.4 Global Antacids Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antacids Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antacids Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antacids Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antacids Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antacids Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antacids Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antacids Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antacids Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antacids Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antacids Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antacids Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antacids Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antacids Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antacids Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antacids Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antacids Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antacids Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antacids Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antacids Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antacids Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antacids Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antacids Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antacids Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antacids Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antacids Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antacids Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antacids Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antacids Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antacids Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antacids Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antacids Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antacids Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antacids Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antacids Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antacids Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antacids Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antacids Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antacids Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antacids Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antacids Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antacids Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antacids Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antacids Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antacids Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antacids Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antacids Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antacids Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antacids Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antacids Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antacids Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antacids Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antacids Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antacids Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antacids Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antacids Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antacids Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antacids Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antacids Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antacids Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antacids Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antacids Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antacids Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antacids Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antacids Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antacids Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antacids Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antacids Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antacids Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antacids Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antacids Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antacids Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antacids Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antacids Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antacids Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antacids Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antacids Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antacids Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antacids Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antacids Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antacids Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antacids Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antacids Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antacids Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antacids Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antacids Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antacids Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xiuzheng Pharma
  2. 8.1.1 Xiuzheng Pharma Company Information
  3. 8.1.2 Xiuzheng Pharma Business Overview
  4. 8.1.3 Xiuzheng Pharma Antacids Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xiuzheng Pharma Antacids Product Portfolio
  6. 8.1.5 Xiuzheng Pharma Recent Developments
  7. 8.2 Takeda Pharmaceutical
  8. 8.2.1 Takeda Pharmaceutical Company Information
  9. 8.2.2 Takeda Pharmaceutical Business Overview
  10. 8.2.3 Takeda Pharmaceutical Antacids Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Antacids Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Antacids Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Antacids Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Antacids Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Antacids Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Antacids Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Antacids Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Reckitt Benckiser
  32. 8.6.1 Reckitt Benckiser Company Information
  33. 8.6.2 Reckitt Benckiser Business Overview
  34. 8.6.3 Reckitt Benckiser Antacids Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Reckitt Benckiser Antacids Product Portfolio
  36. 8.6.5 Reckitt Benckiser Recent Developments
  37. 8.7 CONBA
  38. 8.7.1 CONBA Company Information
  39. 8.7.2 CONBA Business Overview
  40. 8.7.3 CONBA Antacids Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CONBA Antacids Product Portfolio
  42. 8.7.5 CONBA Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Antacids Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Antacids Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 CR SANJIU
  50. 8.9.1 CR SANJIU Company Information
  51. 8.9.2 CR SANJIU Business Overview
  52. 8.9.3 CR SANJIU Antacids Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 CR SANJIU Antacids Product Portfolio
  54. 8.9.5 CR SANJIU Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Antacids Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Antacids Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Bausch Health
  62. 8.11.1 Bausch Health Company Information
  63. 8.11.2 Bausch Health Business Overview
  64. 8.11.3 Bausch Health Antacids Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Bausch Health Antacids Product Portfolio
  66. 8.11.5 Bausch Health Recent Developments
  67. 8.12 Procter & Gamble
  68. 8.12.1 Procter & Gamble Company Information
  69. 8.12.2 Procter & Gamble Business Overview
  70. 8.12.3 Procter & Gamble Antacids Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Procter & Gamble Antacids Product Portfolio
  72. 8.12.5 Procter & Gamble Recent Developments
  73. 8.13 Bayer
  74. 8.13.1 Bayer Company Information
  75. 8.13.2 Bayer Business Overview
  76. 8.13.3 Bayer Antacids Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bayer Antacids Product Portfolio
  78. 8.13.5 Bayer Recent Developments
  79. 8.14 AstraZeneca
  80. 8.14.1 AstraZeneca Company Information
  81. 8.14.2 AstraZeneca Business Overview
  82. 8.14.3 AstraZeneca Antacids Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AstraZeneca Antacids Product Portfolio
  84. 8.14.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antacids Value Chain Analysis
  2. 9.1.1 Antacids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antacids Sales Mode & Process
  6. 9.2 Antacids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antacids Distributors
  9. 9.2.3 Antacids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst